Propofol Interactions

Brand names: Propofol

General Anesthetic

Route: Intravenous

Contraindications

4 CONTRAINDICATIONS Propofol injectable emulsion is contraindicated in patients with a known hypersensitivity to propofol or any of propofol injectable emulsion components. Propofol injectable emulsion is contraindicated in patients with a history of anaphylaxis to eggs, egg products, soybeans or soy products. Known hypersensitivity to propofol, egg or soybean ( 4 )

Pregnancy & Breastfeeding

8.1 Pregnancy Risk Summary Data from randomized controlled trials, cohort studies and case series over several decades with propofol use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Most of the reported exposures to propofol describe propofol exposure at the time of cesarean delivery. There are reports of neonatal depression in infants exposed to propofol during delivery (see Clinical Considerations ) . In animal reproduction studies, decreased pup survival concurrent with increased maternal mortality was observed with intravenous administration of propofol to pregnant rats either prior to mating and during early gestation or during late gestation and early lactation at exposures less than the human induction dose of 2.5 mg/kg. In pregnant rats administered 15 mg/kg/day intravenous propofol (equivalent to the human induction dose) from two weeks prior to mating to early in gestation (Gestation Day 7), offspring that were allowed to mate had increased post implantation losses. The pharmacological activity (anesthesia) of the drug on the mother is probably responsible for the adverse effects seen in the offspring. Published studies in pregnant primates demonstrate that the administration of anesthetic and sedation drugs that block NMDA receptors and/or potentiate GABA activity during the period of peak brain development increases neuronal apoptosis in the developing brain of the offspring when used for longer than 3 hours. There are no data on pregnancy exposures in primates corresponding to periods prior to the third trimester in humans [see Data , Warnings and Precautions (5.3) , and Use in Specific Populations (8.4) ] . The clinical significance of these nonclinical findings is not known, and the benefits of appropriate anesthesia in pregnant women who require procedures should be balanced with the potential risks suggested by the nonclinical data. The estimated background r

24 interactions on record

May increase anesthetic/sedative effects and cardiorespiratory depression; can result in pronounced decreases in blood pressure and cardiac output.

Source: NLP:propofol

May increase anesthetic/sedative effects and cardiorespiratory depression; can result in pronounced decreases in blood pressure and cardiac output.

Source: NLP:propofol

Increases anesthetic/sedative and cardiorespiratory effects of propofol during maintenance anesthesia. Concurrent use is routinely used.

Source: NLP:propofol

Concomitant use may cause enhanced CNS depressant effects. Dosage reduction of dexmedetomidine or propofol may be required.

Source: NLP:dexmedetomidine

May increase anesthetic/sedative effects and cardiorespiratory depression; can result in pronounced decreases in blood pressure and cardiac output.

Source: NLP:propofol

Increases anesthetic/sedative and cardiorespiratory effects of propofol during maintenance anesthesia. Concurrent use is routinely used.

Source: NLP:propofol

May increase anesthetic/sedative effects and cardiorespiratory depression. Concomitant use with propofol may result in serious bradycardia in pediatric patients.

Source: NLP:propofol

Increases anesthetic/sedative and cardiorespiratory effects of propofol during maintenance anesthesia. Concurrent use is routinely used.

Source: NLP:propofol

Increases anesthetic/sedative and cardiorespiratory effects of propofol during maintenance anesthesia. Concurrent use is routinely used.

Source: NLP:propofol

May increase anesthetic/sedative effects and cardiorespiratory depression; can result in pronounced decreases in blood pressure and cardiac output.

Source: NLP:propofol

May increase anesthetic/sedative effects and cardiorespiratory depression; can result in pronounced decreases in blood pressure and cardiac output.

Source: NLP:propofol

May increase anesthetic/sedative effects and cardiorespiratory depression; can result in pronounced decreases in blood pressure and cardiac output.

Source: NLP:propofol

Increases anesthetic/sedative and cardiorespiratory effects of propofol during maintenance anesthesia. Concurrent use is routinely used.

Source: NLP:propofol

May lead to increased blood levels of propofol. Propofol dose should be reduced and patients monitored closely for increased sedation or cardiorespiratory depression.

Source: NLP:propofol

Co-administration with dexmedetomidine hydrochloride leads to enhancement of pharmacodynamic effects. Dosage reduction may be required.

Source: NLP:dexmedetomidine hydrochloride

Dosage adjustment of propofol may be necessary when used concomitantly with divalproex sodium delayed-release tablets.

Source: NLP:divalproex sodium

May increase anesthetic/sedative and cardiorespiratory effects; propofol dose may require adjustment during maintenance.

Source: NLP:propofol

Dosage adjustment of propofol may be necessary if used concomitantly with valproate due to altered pharmacokinetics.

Source: NLP:valproate sodium

Dosage adjustment may be necessary if used concomitantly with valproic acid.

Source: NLP:valproic acid

No clinically significant change in onset, intensity, or duration of action observed.

Source: NLP:propofol